Literature DB >> 20643909

IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota.

A E Budding1, M E Grasman, F Lin, J A Bogaards, D J Soeltan-Kaersenhout, C M J E Vandenbroucke-Grauls, A A van Bodegraven, P H M Savelkoul.   

Abstract

The human intestinal microbiota is known to play an important role in human health and disease, and with the advent of novel molecular techniques, disease-specific variations in its composition have been found. However, analysis of the intestinal microbiota has not yet been applicable in large-scale clinical research or routine diagnostics because of the complex and expensive nature of the techniques needed. Here, we describe a new PCR-based profiling technique for high-throughput analysis of the human intestinal microbiota, which we have termed IS-pro. This technique combines bacterial species differentiation by the length of the 16S-23S rDNA interspace region with instant taxonomic classification by phylum-specific fluorescent labeling of PCR primers. We validated IS-pro in silico, in vitro, and in vivo, on human colonic biopsies and feces, and introduced a standardized protocol for data analysis. IS-pro is easy to implement in general clinical microbiological laboratories with access to capillary gel electrophoresis, and the high-throughput nature of the test makes analysis of large numbers of samples feasible. This combination renders IS-pro ideally suited for use in clinical research and routine diagnostics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643909     DOI: 10.1096/fj.10-156190

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

1.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants.

Authors:  E A M Westerbeek; R A Slump; H N Lafeber; J Knol; G Georgi; W P F Fetter; R M van Elburg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-09       Impact factor: 3.267

3.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

4.  Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease.

Authors:  A Eck; E F J de Groot; T G J de Meij; M Welling; P H M Savelkoul; A E Budding
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

5.  The potential of rectal swabs to differentiate simple and complex appendicitis in children with a microbiota-based test.

Authors:  Sarah-May M L The; Tim G J de Meij; Andries E Budding; Roel Bakx; Johanna H van der Lee; Linda Poort; Huib A Cense; Hugo A Heij; L W Ernst van Heurn; Ramon R Gorter
Journal:  Eur J Pediatr       Date:  2022-10-04       Impact factor: 3.860

6.  Fecal microbiome analysis as a diagnostic test for diverticulitis.

Authors:  L Daniels; A E Budding; N de Korte; A Eck; J A Bogaards; H B Stockmann; E C Consten; P H Savelkoul; M A Boermeester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-04       Impact factor: 3.267

7.  Automated Broad-Range Molecular Detection of Bacteria in Clinical Samples.

Authors:  Andries E Budding; Martine Hoogewerf; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

8.  Reply: Non-transparent and insufficient descriptions of non-validated microbiome methods and related reproductive outcome results should be interpreted with caution.

Authors:  R Koedooder; S Schoenmakers; A E Budding; J S E Laven
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.353

Review 9.  The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.

Authors:  Niels van Best; Peter L Jansen; Sander S Rensen
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

10.  Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.

Authors:  N B M M Rutten; D M W Gorissen; A Eck; L E M Niers; A M Vlieger; I Besseling-van der Vaart; A E Budding; P H M Savelkoul; C K van der Ent; G T Rijkers
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.